Inderal, Inderal LA, Propranolol

Inderal, Inderal LA, Propranolol Newswire

Comprehensive Real-Time News Feed for Inderal, Inderal LA, Propranolol (generic).

Results 1 - 20 of 77 in Inderal, Inderal LA, Propranolol (generic)

  1. Identification of Specific mRNA Signatures as Fingerprints for...Read the original story

    Yesterday | Toxicological Sciences

    KG, Birkendorfer StraAYe 65, 88397 Biberach an der Riss, Germany. Fax: Long-term rodent carcinogenicity studies for evaluation of chemicals and pharmaceuticals concerning their carcinogenic potential to humans are currently receiving critical revision.

    Comment?

  2. Despite ET, life after 50 normal for meRead the original story w/Photo

    Thursday Jan 22 | Clare County Review

    I reached the 50 plateau a few years back, thus I think I know a thing or two about living life at age 50 or over. This week in the Marion Press, as we have done in the REVIEW on occasion, we are offering a special section called 50's Plus Lifestyles.

    Comment?

  3. Yabao Pharmaceutical Group Co., Ltd. (600351) - Pharmaceuticals &...Read the original story

    Sunday Jan 18 | PR-inside.com

    The company manufactures and markets pharmaceuticals products including western and Chinese medicines, APIs, and health care products. Its products include sennae leaf, senna pods, clove, rhubarb, compound zedoary turmeric oil suppositories, povidone iodine suppositories, povidone iodine solution, gemfibrozil capsules, levofloxacin hydrochloride injection, pefloxacin mesylate injection, asarone injection, potassium aspartate and magnesium aspartate injection, simvastatin tablets, propranolol hydrochloride, sustained-release tablets, lovastatin tablets, and mosapride citrate tablets, among others.

    Comment?

  4. Benefits Reported With VT-122 for Advanced Liver and Pancreatic CancersRead the original story

    Friday Jan 16 | P&T Community

    Two studies demonstrated a safety and survival benefit for VT-122 when combined with standard-of-care therapy in patients with advanced liver and pancreatic cancers, according to presentations at the 2015 Gastrointestinal Cancers Symposium in San Francisco. VT-122 is a novel, chrono-modulated combination of the nonelective beta-adrenergic receptor blocker propranolol and the COX-2-selective nonsteroidal anti-inflammatory drug etodolac.

    Comment?

  5. Vicus Therapeutics Announces Safety and Survival Benefit of VT-122 in ...Read the original story

    Friday Jan 16 | Freshnews

    Vicus Therapeutics , an immuno-oncology company focused on bringing breakthrough immunotherapies to patients with solid-tumor cancers, today announced the presentation of two separate studies demonstrating a safety and survival benefit for VT-122, the company's lead compound, when combined with standard-of-care therapy in patients with advanced liver and pancreatic cancers. Results from both studies were presented today at the 2015 Gastrointestinal Cancers Symposium in San Francisco, Calif.

    Comment?

  6. Propranolol, Doxycycline Combo Safe, Effective in RosaceaRead the original story w/Photo

    Tuesday Jan 13 | Mental Help Net

    For patients with rosacea, combination treatment with propranolol and doxycycline is effective and safe, according to a study published in the January issue of the Journal of Dermatology . Jung-Min Park, from Pusan National University in Busan, South Korea, and colleagues conducted a comparative study of propranolol, doxycycline, and combination therapy using both in 78 patients with rosacea.

    Comment?

  7. propranolol, Inderal, Inderal LA, Innopran XLRead the original story w/Photo

    Tuesday Jan 13 | MedicineNet

    Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.

    Comment?

  8. Liver Cirrhosis: A ReviewRead the original story

    Dec 17, 2014 | US Pharmacist

    ABSTRACT: Liver cirrhosis is the result of chronic inflammation and fibrosis of the liver. This disease was recently found to be the 12th leading cause of death in the United States.

    Comment?

  9. Why my potassium citrate gently weepsRead the original story w/Photo

    Dec 13, 2014 | Ask MetaFilter

    I got organized and stored the potassium citrate and propranalol that I take every morning in a pillbox that has 14 little closed plastic compartments. I did this during the summer with no problems that I recall, but as of a couple of weeks ago, the compartments were wet inside.

    Comment?

  10. MKSAP: 50-year-old man with cirrhosisRead the original story w/Photo

    Dec 13, 2014 | Kevin, M.D.

    A 50-year-old man is evaluated in follow-up for a recent diagnosis of cirrhosis secondary to nonalcoholic steatohepatitis. He has a history of asthma, type 2 diabetes mellitus, hyperlipidemia, and obesity.

    Comment?

  11. Drugmaker Pierre Fabre To Slash 551 R&D Jobs By 2016Read the original story

    Dec 9, 2014 | BioSpace

    December 10, 2014 By Mark Terry , BioSpace.com Breaking News Staff French company Pierre Fabre announced on Tuesday that it was cutting 551 jobs in its research and development and sales areas by 2016. Almost all of these positions will be in France.

    Comment?

  12. Proliferating infantile haemangioma: indication of major added...Read the original story w/Photo

    Dec 9, 2014 | Medical News Today

    The Institute for Quality and Efficiency in Health Care investigated in a dossier assessment whether propranolol offers an added benefit in comparison with the appropriate comparator therapy in infants with proliferating infantile haemangioma . According to the findings, there is an indication of major added benefit of propranolol in some children, i.e. those with haemangioma with a risk of permanent scars or disfigurement.

    Comment?

  13. Pricing for new drugs lacks transparencyRead the original story w/Photo

    Dec 8, 2014 | PhysOrg Weblog

    The system that allows patients rapid access to expensive new treatments lacks transparency and penalises small and low-income countries unable to negotiate lower prices with pharmaceutical manufacturers. Writing in the Journal of the Royal Society of Medicine , the authors of an essay on market-access agreements for anti-cancer drugs, say that while the underlying strategy is to help reduce the likelihood of health systems paying for treatments that turn out not to be cost-effective, the agreements can also be seen as an opportunistic way for pharmaceutical manufacturers to keep official prices high.

    Comment?

  14. Study indicates major added benefit of propranolol in some children with haemangiomaRead the original story w/Photo

    Dec 7, 2014 | Medical News

    The Institute for Quality and Efficiency in Health Care investigated in a dossier assessment whether propranolol offers an added benefit in comparison with the appropriate comparator therapy in infants with proliferating infantile haemangioma . According to the findings, there is an indication of major added benefit of propranolol in some children, i.e. those with haemangioma with a risk of permanent scars or disfigurement.

    Comment?

  15. Propranolol in infantile hemangioma: Indication of major added benefit in some patientsRead the original story w/Photo

    Dec 5, 2014 | Science Daily

    Data were only available for children at risk of permanent scars or disfigurement, however, based on this information, scientists report that added benefit of propranolol in infantile hemangioma is proven in other children with proliferating hemangioma. The Institute for Quality and Efficiency in Health Care investigated in a dossier assessment whether propranolol offers an added benefit in comparison with the appropriate comparator therapy in infants with proliferating infantile haemangioma .

    Comment?

  16. Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension.Read the original story

    Dec 5, 2014 | CiteULike

    Beta-blockers are one of the classes of drugs frequently used to treat hypertension. Quantifying the blood pressure lowering effects of nonselective beta-blockers provides important information that aids clinical decision making.

    Comment?

  17. Pierre Fabre Dermatologie Receives The Prix Galien Award For...Read the original story

    Dec 4, 2014 | BioSpace

    Recognition for major progress Each year, the Prix Galien award distinguishes recent therapeutic innovations, made available to the public. It is conferred after an evaluation by an independent panel of experts and eminent specialists.

    Comment?

  18. Mindfulness intervention boosts brain activation for healthy pleasuresRead the original story w/Photo

    Dec 5, 2014 | PhysOrg Weblog

    How can people who are dependent on prescription opioids reduce their cravings? Learn to enjoy other aspects of their lives. That's the key finding in a new study published in the Journal of Behavioral Medicine by Eric L. Garland, associate professor at the University of Utah College of Social Work.

    Comment?

  19. Pierre Fabre Dermatologie Receives the Prix Galien Award for Pharmaceutical Research for ...Read the original story

    Dec 4, 2014 | B3C

    This award is recognition of both Pierre Fabre's expertise in dermatology, one of its development priorities, and of its ability to form public-private partnerships, such as that established with the University of Bordeaux Recognition for major progress Each year, the Prix Galien award distinguishes recent therapeutic innovations, made available to the public. It is conferred after an evaluation by an independent panel of experts and eminent specialists.

    Comment?

  20. Spartan Bioscience Receives Korean Regulatory Approval for First...Read the original story w/Photo

    Nov 27, 2014 | PRWeb

    Millions of Koreans carry CYP2C19 genetic mutations, and the Spartan RX CY2C19 System helps doctors treat them with the most effective drugs.-Paul Lem, M.D., CEO of Spartan Bioscience Spartan Bioscience today announced that it has received South Korean Ministry of Food and Drug Safety regulatory approval for its Spartan RX CYP2C19 System . The system provides genetic results in less than 60 minutes from a non-invasive cheek swab.

    Comment?